Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.7 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |